Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

What You Need To Know Ahead of Clorox's Earnings Release

With a market cap of $16.9 billion, The Clorox Company (CLX) is a leading manufacturer and marketer of consumer and professional products, offering a wide range of trusted brands across health, household, lifestyle, and international markets. Based in Oakland, California, Clorox sells its products globally through various retail and e-commerce channels. CLX is expected to announce its fiscal Q3 2025 earnings results after the market closes on Monday, May 5. 

Ahead of this event, analysts expect the consumer products maker to report a profit of $1.57 per share, down 8.2% from $1.71 per share in the year-ago quarter. However, the company has surpassed Wall Street's earnings estimates in the last four quarters. In Q2 2025, CLX beat the consensus EPS estimate by 11.5%.

 

For fiscal 2025, analysts expect CLX to report an EPS of $7.18, up 16.4% from $6.17 in fiscal 2024.  

www.barchart.com

Shares of CLX have declined 2.3% over the past 52 weeks, lagging behind both the S&P 500 Index's ($SPX) nearly 6% rise and the Consumer Staples Select Sector SPDR Fund’s (XLP12.1% return over the same period. 

www.barchart.com

Despite Clorox reporting better-than-expected Q2 2025 adjusted EPS of $1.55 and revenue of $1.69 billion on Feb. 3, shares dropped 7.2% the next day. Net sales fell 15% year-over-year, compared to a 16% increase in the same quarter last year, largely due to the impact of post-cyberattack inventory normalization and the divestiture of its vitamins, minerals & supplements (VMS) and Argentina businesses. While organic sales guidance was raised to 4% - 7%, overall fiscal 2025 net sales are still expected to be flat to up just 2%.

Analysts' consensus view on Clorox’s stock is cautious, with a "Hold" rating overall. Among 17 analysts covering the stock, one recommends "Strong Buy," 12 suggest "Hold," and four advise "Strong Sell." As of writing, CLX is trading below the average analyst price target of $154.38. 

On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.